Ensysce Biosciences, Inc.
Index- P/E1.23 EPS (ttm)0.45 Insider Own33.90% Shs Outstand6.22M Perf Week-13.47%
Market Cap13.61M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float- Perf Month-48.24%
Income2.90M PEG- EPS next Q- Inst Own14.50% Short Float- Perf Quarter-60.44%
Sales- P/S- EPS this Y978.50% Inst Trans- Short Ratio0.77 Perf Half Y-63.45%
Book/sh0.30 P/B1.85 EPS next Y- ROA22.50% Target Price- Perf Year-95.80%
Cash/sh0.00 P/C- EPS next 5Y- ROE107.10% 52W Range0.57 - 17.12 Perf YTD-88.22%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-96.77% Beta-0.11
Dividend %- Quick Ratio0.70 Sales past 5Y- Gross Margin- 52W Low-3.32% ATR0.10
Employees- Current Ratio0.70 Sales Q/Q-70.90% Oper. Margin- RSI (14)27.92 Volatility10.16% 10.20%
OptionableNo Debt/Eq0.26 EPS Q/Q-197.80% Profit Margin- Rel Volume0.88 Prev Close0.60
ShortableYes LT Debt/Eq0.26 Earnings- Payout0.00% Avg Volume940.29K Price0.55
Recom- SMA20-39.93% SMA50-47.35% SMA200-76.07% Volume836,654 Change-7.08%
May-17-22 08:35AM  
May-12-22 04:10PM  
May-05-22 05:15PM  
Apr-20-22 04:05PM  
Apr-18-22 04:05PM  
Apr-06-22 09:15AM  
Mar-31-22 04:05PM  
Mar-24-22 05:10PM  
Mar-01-22 05:05AM  
Feb-23-22 08:31AM  
Feb-08-22 04:01PM  
Jan-31-22 04:01PM  
Jan-27-22 08:30AM  
Jan-19-22 04:19PM  
Jan-10-22 08:00AM  
Jan-05-22 04:05PM  
Jan-04-22 08:00AM  
Jan-03-22 02:44PM  
Dec-24-21 06:31AM  
Dec-15-21 04:05PM  
Dec-09-21 10:29AM  
Nov-30-21 08:00AM  
Nov-15-21 05:32PM  
Nov-08-21 08:00AM  
Oct-26-21 08:00AM  
Sep-27-21 08:00AM  
Sep-08-21 08:00AM  
Aug-31-21 08:00AM  
Aug-19-21 08:00AM  
Aug-16-21 04:45PM  
Aug-05-21 08:00AM  
Jul-26-21 08:00AM  
Jul-21-21 08:00AM  
Jul-08-21 08:00AM  
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.